CereVasc Receives Approval for STRIDE Clinical Trial of the eShunt® System for the Treatment of Elderly Patients with Normal Pressure Hydrocephalus in Argentina
Hand-out
Press Releases
CereVasc  
February 13, 2025

CereVasc Receives Approval for STRIDE Clinical Trial of the eShunt® System for the Treatment of Elderly Patients with Normal Pressure Hydrocephalus in Argentina

With approval from ANMAT, CereVasc has initiated enrollment of the STRIDE trial in Argentina

avatar profile Olean Times Herald

Olean Times Herald


Local & Social